.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Cytarabine - Generic Drug Details

« Back to Dashboard
Cytarabine is the generic ingredient in three branded drugs marketed by Teva Pharms Usa, Fresenius Kabi Usa, Mylan Labs Ltd, Mylan Pharms Inc, Pacira Pharms Inc, Eurohlth Intl Sarl, Hospira, and Teva Parenteral, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for cytarabine. Six suppliers are listed for this compound.

Summary for Generic Name: cytarabine

Tradenames:3
Patents:0
Applicants:8
NDAs:15
Drug Master File Entries: see list15
Suppliers / Packaging: see list6
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: cytarabine

Clinical Trials for: cytarabine

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eurohlth Intl Sarl
CYTARABINE
cytarabine
INJECTABLE;INJECTION074245-002Aug 31, 1994RXNo
Eurohlth Intl Sarl
CYTARABINE
cytarabine
INJECTABLE;INJECTION071471-001Aug 2, 1989RXNo
Mylan Pharms Inc
CYTARABINE
cytarabine
INJECTABLE;INJECTION200916-001Dec 13, 2011RXNo
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cytarabine

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pacira Pharms Inc
DEPOCYT
cytarabine
INJECTABLE, LIPOSOMAL;INJECTION021041-001Apr 1, 19995,455,044<disabled>
Teva Parenteral
CYTARABINE
cytarabine
INJECTABLE;INJECTION016793-001Approved Prior to Jan 1, 19823,444,294<disabled>
Pacira Pharms Inc
DEPOCYT
cytarabine
INJECTABLE, LIPOSOMAL;INJECTION021041-001Apr 1, 19996,071,534<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc